Trials / Completed
CompletedNCT02431624
An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion
A Two Period, Randomised, Open-label, Crossover Study to Assess the Adhesion of Buprenorphine Transdermal Delivery System 40 µg/h Patch and 20 µg/h Patch, in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Mundipharma Research Limited · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the adhesion of BTDS patch 40 µg/h.
Detailed description
The objective is to show non-inferiority in adhesion of BTDS patch 40 µg/h compared to BTDS patch 20 µg/h. Safety and tolerability of both patches will also be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BTDS |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-05-01
- Completion
- 2015-11-01
- First posted
- 2015-05-01
- Last updated
- 2016-02-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02431624. Inclusion in this directory is not an endorsement.